CEO and founder, nVision Medical
When she was 13, Surbhi Sarna was a patient. It was then that she realised she wanted to fill the void in female-health innovation. Her start-up, nVision Medical, which addresses early detection of ovarian cancer, recently sold to Boston Scientific for $275m. Previous to the acquisition, Surbhi secured $17m in venture-led funding.
Surbhi has authored numerous patents and has been an invited speaker at universities including UCSF and Harvard. She has been featured in publications such as Bloomberg, Entrepreneur magazine and Gigaom, and was named on the Forbes 30 Under 30 list for 2014.